Additions to Schedules in Ss. 961.14, 961.16, 961.18, 961.20 and 961.22, Stats.

CSB 2.38 Addition of suvorexant to schedule IV. Section 961.20 (2) (mr), Stats., is created to read: Section 961.20 (2) (mr) Suvorexant. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register October

CSB 2.39 Exclusion of naloxegol. Section 961.16 (2) (a) (intro.), Stats., is amended to read: 961.16 (2) (a) (intro) Opium and substances derived from opium, and any salt, compound, derivative or preparation of opium or substances derived from opium. Apomorphine, dextrorphan, nal…

CSB 2.40 Exclusion of [123I]ioflupane. Section 961.16 (2) (b), Stats., is amended to read: (b) Coca leaves and any salt, compound, derivative or preparation of coca leaves. Decocainized coca leaves or extractions which do not contain cocaine or ecgonine are excluded from this par…

CSB 2.41 Scheduling of beta-hydroxythiofentanyl and butyryl fentanyl. Sections 961.14 (2) (eu) and (ey) are created to read: 961.14 (2) (eu) Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2yl)ethyl]piperidin-4-yl]-N-phenylpropionamide) (ey) Butyryl fentanyl (N-(1-phenethyl…

CSB 2.42 Scheduling of furanyl fentanyl. Section 961.14 (2) (ne) is created to read: 961.14 (2) (ne) Furanyl fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin-4yl]furan-2-carboxamide). History: EmR1626: emerg. cr., eff. 9-1-16; CR 16-059: cr. Register May 2017 No. 737, eff. 6-1-17…

CSB 2.43 Addition of brivaracetam to schedule V. Section 961.22 (6), Stats., is created to read: 961.22 (6) BRIVARACETAM. Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide), including its salts, isomers or salts of isomers. 8-1-17. CSB 2.019

CSB 2.44 Addition of thiafentanil to schedule II. Section 961.16 (3) 961.16 (10) (a) Dronabinol [(-)-delta-9-trans-tetrahydrocannabinol (delta-9(zx), Stats., is created to read: THC)] in an oral solution in a drug product approved by the U.S. food and drug 961.16 (3) (zx) Thiafen…

CSB 2.45 Addition of AB-FUBINACA and ADB-PINACA to schedule I. Section 961.14 (4) (tb) 32. and 33., Stats., is created to read: 961.14 (4) (tb) 32. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)1H-indazole-3-carboxamide, commonly known as AB-FUBINACA. 33. N-(1-amino-3,3-…

CSB 2.46 Addition of acetyl fentanyl to schedule I. Section 961.14 (2) (ae), Stats., is created to read: 961.14 (2) (ae) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenylacetamide). eff. 12-1-17.

CSB 2.47 Addition of AH-7921 to schedule I. Section 961.14 (2) (aj), Stats., is created to read: 961.14 (2) (aj) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide). eff. 12-1-17.

CSB 2.48 Addition of eluxadoline to schedule IV. Section 961.20 (4) (cm), Stats., is created to read: 961.20 (4) (cm) Eluxadoline, including any of its isomers, and salts of isomers. eff. 12-1-17.

CSB 2.49 Addition of U-47700 to schedule I. Section 961.14 (2) (z), Stats., is created to read: 961.14 (2) (z) U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-Nmethylbenzamide). eff. 12-1-17.

CSB 2.50 Addition of AB-CHMINACA, AB-PINACA and THJ-2201 to schedule I. Section 961.14 (4) (tb) 34., 35., and 36., Stats., are created to read: 961.14 (4) (tb) 34. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)1H-indazole-3-carboxamide, commonly known as AB-CHMINACA. 3…

CSB 2.51 Addition of MAB-CHMINACA to schedule I. Section 961.14 (4) (tb) 37., Stats., is created to read: 961.14 (4) (tb) 37. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, commonly known as MAB-CHMINACA or ADB-CHMINACA. History: cr. Affi…

CSB 2.52 Addition of 4-MePPP and a-PBP to schedule I. Section 961.14 (7) (L) 32. and 33., Stats., is created to read: 961.14 (7) (L) 32. 4-methyl-alpha-pyrrolidinopropiophenone, commonly known as 4-MePPP. 33. Alpha-pyrrolidinobutiophenone, commonly known as a-PBP. History: cr. Af…

CSB 2.53 Scheduling of acryl fentanyl. Section 961.14 (2) (ai), Stats., is created to read: 961.14 (2) (ai) Acryl fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-2propenamide); Section 961.14 (2) (ai), Stats., was renumbered to s. 961.14 (2) (nd) 3. by 2017 Wis. Act 60. Hi…

CSB 2.54 Addition of oral solutions containing dronabinol to schedule II. Section 961.16 (10), Stats., is created to read:

CSB 2.55 Addition of 5F-ADB, 5F-AMB, ADB-FUBINACA, MDMBCHMICA and MDMB-FUBINACA to schedule I. Section 961.14 (4) (tb) 38., 39., 40., 41., and 42., Stats., is created to read: 961.14 (4) (tb) 38. Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)3,3-dimethylbutanoate, common…

CSB 2.56 Addition of 4-fluoroisobutyryl fentanyl to schedule I. Section 961.14 (2) (nd) 10t., Stats., is created to read: 961.14 (2) (nd) 10t. 4-fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1phenethylpiperidin-4-yl)isobutyramide); History: cr. Affirmative action order under s…

CSB 2.57 Scheduling of cyclopropyl fentanyl. Section 961.14 (2) (nd) 10d., Stats., is created to read: 961.14 (2) (nd) 10d. Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenylcyclopropanecarboxamide); History: EmR 1716: emerg. cr. eff. 9-8-17; CR 17-0785: cr. Register Jul…

CSB 2.58 Exclusion of naldemedine. Section 961.16 (2) (a) (intro), Stats., is amended to read: 961.16 (2) (a) (intro) Opium and substances derived from opium, and any salt, compound, derivative or preparation of opium or substances derived from opium. Apomorphine, dextrorphan, na…

CSB 2.59 Addition of ortho-fluorofentanyl to schedule I. Section 961.14 (2) (nd) 16m., Stats., is created to read: 961.14 (2) (nd) 16m. Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1phenethylpiperidin-4-yl)propionamide);

CSB 2.60 Addition of FUB-AMB to schedule I. Section 961.14 (4) (tb) 43., Stats., is created to read: 961.14 (4) (tb) 43. methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3methylbutanoate, commonly known as FUB-AMB, MMB-FUBINACA or AMBFUBINACA.

CSB 2.61 Addition of MT-45 to schedule I. Section 961.14 (2) (rk), Stats., is created to read: 961.14 (2) (rk) MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine); History: cr. Affirmative action order under s. 961.11 (4), Stats., Register January 2018 No. 745, eff. 1-22-18; cor…

CSB 2.62 Addition of para-chloroisobutyryl fentanyl to schedule I. Section 961.14 (2) (nd) 16s., Stats., is created to read: 961.14 (2) (nd) 16s. Para-chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1phenethylpiperidin-4-yl)isobutyramide); History: cr. Affirmative action order u…

CSB 2.63 Addition of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA to schedule I. Section 961.14 (4) (tb) 44., 45., 46., 47., and 48., Stats., are created to read: 961.14 (4) (tb) 44. Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate, commonly…

CSB 2.64 Addition of N-Ethylpentylone to schedule I. Section 961.14 (7) (L) 34., Stats., is created to read: 961.14 (7) (L) 34. N-Ethylpentylone, commonly known as ephylone. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register October

CSB 2.65 Addition of approved cannabidiol drugs to schedule V. Section 961.22 (7), Stats., is created to read: 961.22 (7) Approved cannabidiol drugs. A drug product in finished dosage formulation that has been approved by the United States food and drug administration that contai…

CSB 2.66 Addition of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUBAKB48, 5F-CUMYL-PINACA, and FUB-144 to schedule I. Section 961.14 (4) (tb), 49., 50., 51., 52., and 53., Stats., are created to read: 961.14 (4) (tb) 49. Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3dimethylbutano…

CSB 2.67 Addition of Brexanolone and Solriamfetol to schedule IV. Section 961.20 (2) (ap) and (2m) (g), Stats., are created to read: 961.20 (2) (ap) Brexanolone; (2m) (g) Solriamfetol. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register July

CSB 2.68 Addition of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8 and 4-chloro-a-PVP to schedule I. Section 961.14 (7) (L) 35. to 40., Stats., is created to read: 961.14 (7) (L) 35. N-Ethylhexedrone. 36. Alpha-pyrrolidinohexanophenone, commonly known as a-PHP. 37. 4-methyl-alpha-et…

CSB 2.69 Addition of Noroxymorphone to schedule II. Section 961.16 (2) (a) 10m., Stats., is created to read: 961.16 (2) (a) 10m. Noroxymorphone.

CSB 2.70 Scheduling 4F-MDMB-BINACA and MMB-FUBICA. Section 961.14 (4) (tb) 38m. and 43m., Stats., are created to read: 961.14 (4) (tb) 38m. Methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)3,3-dimethylbutanoate, commonly known as 4F-MDMB-BINACA or 4F-MDMBBUTINACA. 43m. Methy…

CSB 2.71 Addition of lasmiditan to schedule V. Section 961.22 (8), Stats., is created to read: the chapter was last published. 9 CONTROLLED SUBSTANCES BOARD 961.22 (8). Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide]. History: cr. Affirmat…

CSB 2.72 Scheduling of isotonitazene and 1P-LSD. Section 961.14 (2) (pe) and (4) (jm), Stats., are created to read: 961.14 (2) (pe) Isotonitazene; 961.14 (4) (jm) 1-propionyl-lysergic acid diethylamide, commonly known as 1PLSD; History: EmR2013: emerg. cr., eff. 6-5-20; CR 20-023…

CSB 2.73 Addition of cenobamate to schedule V. Section 961.22 (9), Stats., is created to read: 961.22 (9) CENOBAMATE Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol2-yl)ethyl] carbamate; 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid…

CSB 2.74 Addition of Lemborexant to schedule IV. Section 961.20 (2) (eqm), Stats., is created to read: 961.20 (2) (eqm) Lemborexant. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register March

CSB 2.75 Exclusion of approved cannabidiol drugs from schedule I. (1) Section 961.14 (4) (t) 4., Stats., is created to read: 961.14 (4) (t) 4. A drug product in finished dosage formulation that has been approved by the United States food and drug administration that contains cann…

CSB 2.76 Addition of norfentanyl to schedule II. (1) Section 961.16 (8) (b), Stats., is renumbered 961.16 (8) (b) (intro.) and amended to read: 961.16 (8) (b) An immediate precursor to fentanyl, including all of the following: 1. 4-anilino-N-phenethyl-4-piperidine, commonly known…

CSB 2.77 Scheduling of flualprazolam. Section 961.20 (2) (ef), Stats., is created to read: 961.20 (2) (ef) Flualprazolam; History: EmR1037: emerg. cr., eff. 10-27-20; CR 20-078: cr. Register July 2021 No. 787, eff. 8-1-21; correction made under s. 35.17, Stats., Register July 202…

CSB 2.78 Addition of crotonyl fentanyl to schedule I. Section 961.14 (2) (nd) 9m., Stats., is created to read: 961.14 (2) (nd) 9m. Crotonyl Fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-Nphenylbut-2- enamide);

CSB 2.79 Addition of remimazolam to schedule IV. Section 961.20 (2) (mo), Stats., is created to read: 961.20 (2) (mo) Remimazolam;

CSB 2.80 Scheduling of oliceridine. Section 961.16 (3) (ta), Stats., is created to read: 961.16 (3) (ta) Oliceridine; 9-1-22.

CSB 2.81 Addition of brorphine to schedule I. Section 961.14 (2) (et), Stats., is created to read: 961.14 (2) (et) Brorphine; History: cr. Affirmative action order under s. 961.11 (4), Stats., Register May 2021 No. 785, eff. 4-26-21; correction made under s. 35.17, Stats., Regist…

tion 961.20 (2m) (em), Stats., is created to read: the chapter was last published. CSB 2.019 WISCONSIN ADMINISTRATIVE CODE

CSB 2.83 Addition of ten (10) fentanyl-related substances to schedule I. Section 961.14 (2) (nd) 21., 22., 23., 24., 25., 26., 27., 28., 29., and 30., Stats., is created to read: 961.14 (2) (nd) 21. N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide (2’-fluoro…

CSB 2.84 Addition of alfaxalone to schedule IV. (1) Section 961.20 (2) (a), Stat., is repealed and recreated to read: 961.20 (2) (a) Alfaxalone; (2) Section 961.20 (2) (ak) is created to read: 961.20 (2) (ak) Alprazolam; History: cr. Affirmative action order under s. 961.11 (4), …